financetom
Business
financetom
/
Business
/
SocGen Previews Wednesday's Bank of Canada Policy Meeting; Comments on Canadian Dollar
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
SocGen Previews Wednesday's Bank of Canada Policy Meeting; Comments on Canadian Dollar
Jul 30, 2025 4:26 AM

07:02 AM EDT, 07/30/2025 (MT Newswires) -- The Bank of Canada is likely to leave its policy rate unchanged at 2.75% on Wednesday at 9:45 a.m. ET, delivering a third successive status quo, said Societe Generale.

Money markets price in a status but haven't given up one further cut before year-end, wrote the bank in a note to clients.

Headline inflation was subdued at 1.9% year over year in June and has remained below the 2% mid-point of the 1%-3% target for three straight months, while the core rate was at or above 3%.

Further policy easing isn't ruled out however, given the fractious trade negotiations with the United States, stated SocGen. The BoC business outlook for future sales collapsed to six points in Q2 from 13 in Q1 and the overall business outlook survey worsened to -2.4 points in Q2 from -2.1 points in Q1.

The slack in the economy and tariff hostilities justify the pricing of at least one more rate cut this year to 2.50%, added the bank. The bottom end of the neutral range is 2.25%.

Dollar buy-backs returned USD/CAD to the upper end of the two-month range near 1.38. An acceleration back towards 1.40 (200dma 1.4045) is still a long shot but cannot be ruled out if U.S. trade negotiations take a turn for the worse and additional Federal Reserve easing is taken out of the equation, according to SocGen.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Copyright 2023-2026 - www.financetom.com All Rights Reserved